AMSTERDAM - New York Oncology Hematology is investing more than $3 million in its Amsterdam Cancer Center, at 1700 Riverfront Center, a news release said.
NYOH is fully replacing its radiation technology service line, the release said. The new equipment will be a Varian iX linear accelerator (known as a "linac") and General Electric CT Simulator, the release said.
"Investing in this new technology will allow us to continue providing patients with the best radiation treatments available," Dr. Arsyl De Jesus, radiation oncologist at NYOH's Amsterdam Cancer Center, said in the release. "With built in x-ray and CT imaging systems, the linac will allow us to better target cancer in real-time."
New York Oncology Hematology will be investing $3 million in new radiation technology for its Amsterdam Cancer Center, located in the Riverfront Center. Dr. Todd Doyle, right, a radiation oncologist, and Heather Broekema, a radiation therapist, use a medical-grade linear accelerator — known as a “linac” — at NYOH’s Albany Cancer Center. The linac is one of two new pieces of equipment coming to Amsterdam, a news release said.
Used for radiation treatment planning, the General Electric Lightspeed CT Simulator uses special imaging techniques to scan more quickly, while more precisely defining the size, shape and location of tumors, the release said.
Office renovations are also planned to accommodate the new technology, the release said.
Radiation renovations will begin in March and are expected to finish in June. In the interim, radiation patients will continue to be served at NYOH offices in Rexford and at Patroon Creek in Albany, Dr. Nini Wu, president of New York Oncology Hematology, said in the release.
New York Oncology Hematology (then Albany Regional Cancer) first opened in Amsterdam in 1986, moving to its current location at Riverfront Center in 1999. It also has locations in Albany, Hudson, Latham, Rexford and Troy.
"Thanks to New York Oncology Hematology's investment it its Amsterdam Cancer Center, more families will have convenient access to state of the art cancer treatment right in our own community," U.S. Rep. Paul Tonko, D-Amsterdam, said in a news release. "In addition to their major investment, we also recognize NYOH as a vital catalyst, spurring economic development through its planned improvements to Riverfront Center."
Dr. Robert H. Goslin, medical oncologist at NYOH's Amsterdam Cancer Center, said in the release that he and other physicians will continue to see new and existing medical oncology patients in the Amsterdam office.